Abbreviations used in this paper: \[Ca^2+^\]~i~, intracellular Ca^2+^ concentration; GPCR, G protein--coupled receptor; IP~3~, inositol 1,4,5-trisphosphate; PIP5KIγ, type I phosphatidylinositol 4-phosphate 5-kinase γ; PIP~2~, phosphatidylinositol 4,5-bisphosphate; PM, plasma membrane; RNAi, RNA interference; siRNA, small interfering RNA.

Introduction
============

Phosphatidylinositol 4,5-bisphosphate (PIP~2~) regulates multiple plasma membrane (PM) functions ([@bib4]; [@bib26]), and it is also a substrate for PLC-mediated inositol 1,4,5-trisphosphate (InsP~3~ or IP~3~) generation. In spite of PIP~2~\'s obligatory role as an IP~3~ precursor, and the importance of IP~3~ mediated Ca^2+^ signaling, surprisingly little is known about the identity of the phosphoinositide kinases involved. Unlike yeast, which has a single type I phosphatidylinositol 4-phosphate 5-kinase (PIP5KI) that synthesizes PIP~2~ ([@bib1]), mammals have three major PIP5KI isoforms named α, β and γ ([@bib4]).

PIP5KIγ has two splice variants (PIP5KIγ87 and 90) that are distinguished by a 28--amino acid extension at the COOH terminus of PIP5KIγ90 ([@bib3]; [@bib10]; [Fig. 1](#fig1){ref-type="fig"} A). PIP5KIγ90 is particularly enriched in neurons ([@bib25]); it is the major PIP~2~ synthesizing enzyme at the synapse, where it has been implicated in the regulation of clathrin coat recruitment, actin dynamics ([@bib25]) and focal adhesion formation ([@bib3]; [@bib10]). In contrast, PIP5KIγ87 is not involved in focal adhesion formation or clathrin-mediated endocytosis (in HeLa cells; [@bib15]).

![**PIP5KIγ RNAi.** (A) PIP5KIγ siRNA design. Pan siRNA is directed against both isoforms. (B) PIP5KIγ protein knockdown. Effect of PIP5Kγ RNAi on protein expression of the targeted and nontargeted PIP5KIs. Western blots were probed with isoform specific antibodies. Additional data are provided in Table S1, available at <http://www.jcb.org/cgi/content/full/jcb.200408008/DC1>. (C) Quantitative real-time PCR. PCR primers were used to quantitate PIP5KIγpan and PIP5KIγ90 mRNA and PIP5KIγ87 mRNA was calculated from the difference. Numbers indicate the amounts of each isoform relative to PIP5KIγ90 in control cells. Data are the average of duplicate RNAi samples from a single experiment. Similar results were obtained from another experiment. (D) PIP5KIγ is enriched in the PM. Endogenous PIP5KIγ was detected with anti-PIP5KIγpan antibody, and overexpressed HA-PIP5KIγ87 (in cDNA-transfected cells) were stained with anti-HA. Arrows indicate PM. Bars, 50 μm. **(**E) Differential PIP5KI membrane association. Fractions obtained after sequential sedimentation were loaded equivalently, except for the cytosol fraction (CYT), which was loaded 10 times less. Western blot band intensity was determined by quantitative densitometry, and expressed as a percent of total recovered, after correcting for differences in fraction of sample loaded.](200408008f1){#fig1}

Here, we examined the role of PIP5KIγ87 in intracellular Ca^2+^ signaling. Previous biochemical studies have shown that cells have agonist-sensitive and -insensitive PIP~2~ pools ([@bib8]). Inhibitor studies suggest that the agonist-sensitive pool can be further classified as constitutive or de novo generated in response to agonists ([@bib12]). Some of these pools are enriched in cholesterol--sphingolipid raft domains ([@bib17]) and the stringent spatial and temporal regulation of Ca^2+^ may be specified by assembling key players into supramolecular signaling complexes ([@bib2]). We now report that PIP5KIγ87 is the major source of the agonist-sensitive PM PIP~2~ pool that fuels the initial Ca^2+^ response to external stimuli.

Results and discussion
======================

Knockdown of PIP5KIγ87 by RNA interference
------------------------------------------

We use small interfering RNA (siRNA) mediated RNA interference (RNAi) to knockdown each PIP5KI individually ([@bib15]). Anti-PIP5KIγpan antibody recognizes a sharp 87-kD band and a slower migrating diffuse band ([Fig. 1](#fig1){ref-type="fig"} B) which is probably hyperphosphorylated PIP5KIγ87 ([@bib16]; [@bib25]). Anti-PIP5KIγpan stains the PM, the perinuclear region and the nucleus ([Fig. 1](#fig1){ref-type="fig"} D). Low level HA-PIP5KIγ87 overexpression confirms that PIP5KIγ is enriched in the PM and punctate internal structures, but rules out nuclear localization.

Biochemical fractionation shows that 60% of PIP5KIγ87 is sedimented by high speed centrifugation ([Fig. 1](#fig1){ref-type="fig"} E), and approximately two thirds of this is associated with the PM enriched fraction. PIP5KIα is much more membrane bound, whereas PIP5KIβ is least membrane associated. Therefore, these PIP5KIs have different patterns of membrane association. Nevertheless, each can potentially generate PIP~2~ at the PM and internal membranes.

Because it is not possible to knockdown PIP5KIγ87 exclusively, we compared the effects of siRNA directed against both PIP5KIγ isoforms (PIP5KIγpan) to that of PIP5KIγ90 alone. PIP5KIγpan siRNA decreases all PIP5KIγ bands in Western blots ([Fig. 1](#fig1){ref-type="fig"} B) and reduces PM and cytoplasmic anti-PIP5KIγ immunofluorescence, but not the nonspecific nuclear staining ([Fig. 1](#fig1){ref-type="fig"} D). PIP5KIγ90 siRNA has little effect on either PIP5KIγ bands ([Fig. 1](#fig1){ref-type="fig"} B), even though quantitative real-time PCR established that PIP5KIγ90 mRNA is decreased by 70% ([Fig. 1](#fig1){ref-type="fig"} C). We conclude that HeLa cells have very little PIP5KIγ90.

Unexpectedly, PIP5KIγpan siRNA preferentially knocks down PIP5Kγ87 mRNA relative to PIP5KIγ90. Because PIP5Kγ87 is more abundant than PIP5Kγ90 in HeLa cells and PIP5Kγpan siRNA generates a distinct phenotype (compared with that of PIP5Kγ90 siRNA), the PIP5KIγpan siRNA effects described here can be attributed primarily to PIP5KIγ87 knockdown. Importantly, PIP5KIγpan siRNA has almost no effect on PIP5KIα and β protein expression ([Fig. 1](#fig1){ref-type="fig"} B), establishing that the PIP5KIγ87 knockdown phenotype is not complicated by compensatory changes in the other PIP5KIs. This was originally a concern, because we have previously found that knockdown of one PIP5KI induces changes in the mRNA level of some other PIP5KIs ([@bib15]).

PIP5KIγ87 is the major supplier of the PIP~2~ pool that supports GPCR-mediated Ca^2+^ signaling
-----------------------------------------------------------------------------------------------

Histamine binding to the H1 type G protein--coupled receptor (GPCR) in HeLa cells ([@bib20]) initiates a PLCβ activation cascade that culminates in the hydrolysis of PIP~2~ to generate IP~3~ and diacylglycerol. When control cells were stimulated with a supramaximal histamine dose (100 μM), they generate a transient robust IP~3~ response ([Fig. 2](#fig2){ref-type="fig"} A). PIP5KIγ87 RNAi decreases the initial IP~3~ peak by 69% \[to 10 ± 3 pmol IP~3~/mg protein (*n* = 5)\] ([Fig. 2, A and B](#fig2){ref-type="fig"}). Neither PIP5KIγ90 nor PIP5KIβ RNAi has any apparent effect, and PIP5KIα RNAi only decreases the initial IP~3~ peak slightly \[by 11%; to 28 ± 2 pmol/mg protein (*n* = 3)\] ([Fig. 2](#fig2){ref-type="fig"} B). Although we cannot rule out a small contribution by PIP5KIβ or α because each is less completely knocked down than PIP5KIγ, we can conclude that PIP5KIγ87 is the dominant regulator.

![**PIP5KIγpan siRNA blocks histamine-stimulated IP~3~ generation.** Cells were stimulated with 100 μM histamine. (A) Effect of PIP5KIγpan siRNA on IP~3~ generation. Data shown are representative of five independent experiments. (B) Effect of PIP5KI RNAi on the initial IP~3~ peak response. Values are mean ± SEM of multiple independent experiments (n).](200408008f2){#fig2}

Consistent with a decrease in IP~3~ production, PIP5KIγpan RNAi also attenuates histamine-induced Ca^2+^ signaling. In control cells, 100 μM histamine induces a rapid and transient rise in intracellular Ca^2+^ concentration (\[Ca^2+^\]~i~) in 95% of the cells examined ([Fig. 3](#fig3){ref-type="fig"} A). PIP5KIγ87 RNAi reduces the percent of responding cells slightly (by 13%), decreases the amplitude of the first Ca^2+^ peak more \[by 36%; from 1.14 ± 0.07 (*n* = 19) to 0.73 ± 0.08 (*n* = 10) fluorescence ratio unit\], and has the most impact on Ca^2+^ flux \[76% decrease; from 0.33 ± 0.03 (*n* = 19) to 0.08 ± 0.01 (*n* = 10) unit/s\] ([Fig. 3](#fig3){ref-type="fig"} A). Because Ca^2+^ flux correlates with the open probability of the IP~3~Rs and hence the rate of IP~3~ generation ([@bib7]), our results establish that PIP5KIγ87 RNAi depletes the PIP~2~ pool used for IP~3~ generation. A similarly large decrease in Ca^2+^ flux was also observed when PIP~2~ was depleted by overexpressing the PIP~2~ phosphatase synaptojanin ([@bib7]).

![**PIP5KIγpan siRNA attenuates intracellular Ca** ^2**+**^ **signaling.** Cells loaded with fura2-AM in randomly chosen microscopic fields were ratio imaged (F~340~/F~380~) to obtain baseline Ca^2+^ values. Histamine was added in the absence of extracellular Ca^2+^, and the ratio image was recorded as a function of time. (A) Ca^2+^ response to 100 μM histamine (indicated by the arrow). Representative tracings for each type of RNAi are shown. Values in bar graphs are expressed as percent (mean ± SEM) of control. (B) In vivo rescue of intracellular Ca^2+^ signaling in PIP5KIγpan siRNA-treated cells by Shuttle PIP~2~. Top panels are representative tracings. (Bottom) The Ca^2+^ flux of the transients elicited by the second histamine addition was plotted and 10 cells were analyzed per condition.](200408008f3){#fig3}

The weakened Ca^2+^ response by PIP5KIγ87 RNAi cells is not due to depletion of Ca^2+^ stores, because thapsigargin releases similar amounts of Ca^2+^ into the cytosol of control and siRNA cells (unpublished data). The \[Ca^2+^\]~i~ response to UTP, which binds a different GPCR than histamine (P2Y and H1, respectively), is blunted as well (unpublished data). \[Ca^2+^\]~i~ increase in the presence of 1.3 mM of extracellular Ca^2+^ (Table S2, available at <http://www.jcb.org/cgi/content/full/jcb.200408008/DC1>) is also attenuated, confirming that the lack of PIP~2~ impacts the entire Ca^2+^ signaling cascade that starts with Ca^2+^ release from internal stores and ends with capacitative Ca^2+^ entry (that usually follows the depletion of intracellular Ca^2+^ stores).

As expected, in control cells, 1 μM histamine induces a slower Ca^2+^ flux than 100 μM histamine \[0.24 ± 0.01 (*n* = 63) vs. 0.33 ± 0.03 (*n* = 19) fluorescence ratio unit/s\]. Paradoxically, PIP5KIγ87 RNAi cells have the same low Ca^2+^ flux \[0.08 ± 0.01 (*n* = 46) vs. 0.08 ± 0.01 (*n* = 10) fluorescence ratio unit/s\] at both histamine doses. We cannot explain why this is the case. Perhaps because PIP~2~ is already limiting at submaximal stimulation, increasing the intensity of the stimulus does not significantly increase the amount of IP~3~ generated due to lack of substrate.

Unlike PIP5KIγ87 RNAi, PIP5KIγ90, α or β RNAi has much less effects ([Fig. 3](#fig3){ref-type="fig"} A), paralleling the trend observed with IP~3~ production ([Fig. 2](#fig2){ref-type="fig"} B). Thus, the PIP5KIγpan siRNA phenotype can be most simply explained by a decrease in the amount of PLCβ accessible PM PIP~2~ and that this pool is generated primarily by PIP5KIγ87.

If PIP5KIγ87 RNAi suppresses Ca^2+^ signaling by depleting PM PIP~2~, restoring membrane PIP~2~ should rescue the Ca^2+^ response. We used a membrane permeant polyamine shuttle carrier to deliver exogenous PIP~2~ into intact cells ([@bib14]; [@bib22]). Control HeLa cells respond to sequential histamine challenges identically, and Shuttle PIP~2~ does not change the Ca^2+^ response significantly ([Fig. 3](#fig3){ref-type="fig"} B). PIP5KIγ87 RNAi cells, which are already less responsive to the first stimulus than control cells, have an even more blunted response to the second stimulus in the absence of Shuttle PIP~2~ ([Fig. 3](#fig3){ref-type="fig"} B, left). This is consistent with depletion of the already small PIP~2~ pool by the first stimulus, and inadequate refilling before the second stimulus. Significantly, Shuttle PIP~2~ restores the Ca^2+^ response of PIP5KIγ87 RNAi cells to ∼74% of that observed in Ctrl RNAi cells ([Fig. 3](#fig3){ref-type="fig"} B). Therefore, the Ca^2+^ signaling defect is due to PIP~2~ depletion by PIP5KIγ RNAi.

Together, our results demonstrate that PIP5KIγ87 has a critical role in GPCR-mediated IP~3~ signaling in HeLa cells. Interestingly, overexpressed mouse PIP5KIβ (equivalent to human PIP5KIα described in this paper) stimulates tyrosine kinase receptor activated-IP~3~ generation in B lymphocytes ([@bib18]). Together, these results raise the intriguing possibility that the GPCR- and tyrosine kinase receptor-coupled PIP~2~ pools may be governed by different PIP5KIs. We plan to determine if this is the case in future studies.

Effects of PIP5KIγ87 RNAi on PIP~2~ content and distribution
------------------------------------------------------------

To understand how PIP5KIγ87 uniquely contributes to GPCR mediated IP~3~ signaling, we estimated the size and location of its PIP~2~ pool relative to those of other PIP5KIs. PIP5KIγpan siRNA reduces PIP~2~ mass, determined by HPLC ([@bib13]), by 14% \[from 377 ± 90 (*n* = 3) to 325 ± 95 (*n* = 3) pmol/mg protein\] and ^32^P-incorporation into PIP~2~, determined by TLC, to a similar extent ([Fig. 4](#fig4){ref-type="fig"} A). PIP5KIγ90 siRNA has no statistically significant effect. PIP5KIβ RNAi decreases PIP~2~ mass by 34% ([Fig. 4](#fig4){ref-type="fig"} A), which is consistent with the large decrease in \[^32^P\]PIP~2~ reported previously ([@bib15]). Paradoxically, although PIP5KIα RNAi does not decrease \[^32^P\]PIP~2~ ([@bib15]), it decreases PIP~2~ mass by 33%. The difference between the TLC and HPLC estimates may be because they measure different parameters. ^32^P-labeling/TLC detects PIP~2~ that turns over during the labeling period, whereas the HPLC method does not involve radiolabeling ([@bib13]) and measures PIP~2~ mass. It is possible that the 4-h labeling interval we used was not long enough to completely equilibrate a particularly stable PIP~2~ pool, and therefore underestimates its size.

![**Effect of PIP5KI RNAi on PIP~2~.** (A) PIP~2~ mass (HPLC) and ^32^P-incorporation (TLC). Means ± SEM of independent experiments are shown. (B**)** PIP~2~ distribution as detected with anti-PIP~2~ and overexpressed GFP-PLCδ-PH. Cross-sectional plots of fluorescence intensity are shown next to the image. Bars, 50 μm. (C) Analysis of PIP~2~ quantitation. (Left) The average intensities of anti-PIP~2~ at the PM and inside the cell are expressed in arbitrary units (mean ± SEM). 10 cells were analyzed per RNAi condition. (Right) PM/cytoplasmic intensity ratios of anti-PIP~2~ and GFP-PLCδ-PH were shown. 10 cells were analyzed per label per RNAi condition.](200408008f4){#fig4}

PIP5KIγ87 RNAi decreases PM PIP~2~ significantly. PIP~2~ was detected by single cell fluorescence imaging using overexpressed GFP-PLCδ-PH ([@bib21]; [@bib23]) and anti-PIP~2~ ([@bib9]; [@bib11]; [Fig. 4](#fig4){ref-type="fig"} B). Although it is generally accepted that the PM is particularly enriched in PIP~2~ and that GFP-PLCδ-PH labels the PM intensely, internal GFP-PLCδ-PH labeling has also been reported in at least some types of cells ([@bib11]). However, because GFP-PLCδ-PH was overexpressed and also binds IP~3~ ([@bib6]), it is difficult to determine if the internal GFP-PLCδ-PH is bound to PIP~2~/IP~3~ or represents unliganded PH. This issue is clarified somewhat by a quantitative immuno-electron microscopic study which shows that the PM accounts for 40% of total GST-PLCδ-PH labeling, and internal organelles account for the remainder ([@bib23]).

Our anti-PIP~2~ staining results clearly shows that PIP~2~ is present in internal membranes as well as PM in HeLa cells. Using image quantitation ([Fig. 4, B and C](#fig4){ref-type="fig"}), we estimate that anti-PIP~2~ fluorescence in the vicinity of the PM accounts for 12.3 ± 1.2% (*n* = 10) of total, and its intensity is 1.54 ± 0.13 times (*n* = 10) higher than in internal sites (PM/cytosol ratio; [Fig. 4](#fig4){ref-type="fig"} C). Although these cross-sectional analyses underestimate the size of the PM pool (compared with morphometric analysis by electron microscopy, as described by [@bib23]), it can be used to compare the effects of different PIP5KI RNAi.

PIP5KIγpan RNAi decreases the PM anti-PIP~2~ intensity from 226 ± 7 to 134 ± 8 arbitrary units (59% of control) and internal PIP~2~ from 157 ± 12 to 130 ± 12 arbitrary units (84% of control; [Fig. 4](#fig4){ref-type="fig"} C). Therefore, PM PIP~2~ is preferentially depleted. PIP5KIβ RNAi decreases anti-PIP~2~ intensity at the PM to the same extent (to 58% of control; [Fig. 4](#fig4){ref-type="fig"} B) but has a greater effect on internal PIP~2~ (71% of control). In contrast, PIP5KIα RNAi has no detectable effect on PM PIP~2~ (98% remains after RNAi), but decreases internal staining (76% remaining; [Fig. 4, B and C](#fig4){ref-type="fig"}). The differential responses of PM versus internal PIP~2~ is evident when the average intensity of PM PIP~2~ is expressed as a ratio to that in the cytosol ([Fig. 4](#fig4){ref-type="fig"} C, right). Qualitatively similar, but not identical, changes are also observed with GFP-PLCδ-PH ([Fig. 4](#fig4){ref-type="fig"} C). Thus, these two independent methods both show that PIP5KIγ87 and PIP5KIβ RNAi decrease PM PIP~2~, even though only the former suppresses GPCR-mediated IP~3~/Ca^2+^ signaling.

In conclusion, PIP5KIγ87 is the major source of the GPCR mobilized PIP~2~ pool. This specialized PIP~2~ accounts for a small fraction of total PIP~2~, a significant fraction of PM PIP~2~ and most of the histamine induced IP~3~ response. The exquisitely selective effect of PIP5KIγ87 RNAi on Ca^2+^ signaling suggests that the cell\'s PIP~2~ is functionally compartmentalized in a PIP5KI-dependent manner. This study provides a mechanistic understanding of how PIP~2~ can regulate multiple PM functions independently. Additional studies will determine if PIP5KIγ87 is part of the supramolecular PLCβ signaling scaffold that specifies rapid local Ca^2+^ generation and propagation ([@bib2]), and whether the functionally compartmentalized PIP~2~ is physically segregated in the PM.

Materials and methods
=====================

Antibodies
----------

Anti-PIP5KIα was purchased from Santa Cruz Biotechnology, Inc. Anti-PIP5KIβ and PIP5KIγpan were gifts from C. Carpenter (Harvard Medical School, Boston, MA) and P. De Camilli (Yale University, New Haven, CT; [@bib25]), respectively. Monoclonal anti-PIP~2~ ([@bib5]) was a gift from K. Fukami (University of Tokyo, Tokyo, Japan).

RNAi
----

We used the human PIP5KI isoforms designation, which is different from the mouse designation. siRNA oligonucleotides were performed as described previously ([@bib15]). HeLa cells were transfected with the siRNA and used 48--72 h later.

Quantitative real-time PCR
--------------------------

RNA extracted from HeLa cells transfected with siRNA were reverse transcribed and used for PCR in a sequence detection system (Prism 7000; Applied Biosystems). Primers directed at nucleotides 414--478 (pan) and 1993--2048 (unique to PIP5KIγ90) were used ([@bib15]).

PIP~2~ measurements
-------------------

PIP~2~ mass was determined by a nonradioactive HPLC detection system ([@bib13]). ^32^P-incorporation into PIP~2~ was determined by labeling cells for 4 h with ^32^P-PO~4~ (NEN Life Science Products), resolving lipids by TLC, and quantitation by phosphorimager analysis ([@bib22]). PM PIP~2~ was determined by image analysis of cells overexpressing low amounts of GFP-PLCδ-PH ([@bib21]), or labeling with anti-PIP~2~ ([@bib9]; [@bib11]). Fluorescence images were captured by confocal microscopy (model LSM5; Carl Zeiss MicroImaging, Inc.) and intensity plots were analyzed by MetaMorph Offline software ([@bib21]). The average fluorescence intensity of the two cell edges and between the cell edges were defined as PM and cytoplasmic PIP~2~, respectively, and are expressed in arbitrary units.

Immunofluorescence microscopy
-----------------------------

For most purposes, 0.4% formaldehyde fixed cells were permeabilized with Triton X-100 and processed for confocal microscopy as described previously ([@bib22]). Anti-PIP~2~ staining was detected by permeabilizing fixed cells with 10 μg/ml digitonin, which preserves the lipid signal better than Triton X-100.

Multistep membrane fractionation
--------------------------------

Cells were homogenized by 25 strokes in a prechilled steel homogenizer and homogenates were centrifuged sequentially to obtain the crude organelle/membrane fractions as described previously ([@bib24]). LSP is enriched for Golgi membranes and early endosomes, and HSP is enriched for lysosomes and late endosomes. The PM fraction was obtained by placing the 19,000 *g* pellet on top of a sucrose cushion, and collecting the membranes at the top after centrifugation at 100,000 *g*.

IP~3~ measurement
-----------------

Cell monolayers incubated in Ca^2+^-free Hank\'s buffer supplemented with 0.1% BSA were stimulated with 100 μM histamine (Sigma-Aldrich) for 0--25 s at RT and the reaction was stopped with PCA. IP~3~ content was assayed by competition with exogenous \[^3^H\]IP~3~ to bind calf cerebellar microsomes ([@bib19]).

Single cell Ca^2+^ imaging
--------------------------

Cells plated on glass-bottom culture dishes (Mat Tek) were loaded with fura2/AM, washed and incubated for 30 min at RT to allow de-esterification of the loaded dye. The dish was mounted on the stage of an inverted fluorescence microscope (Axiovert 200; Carl Zeiss MicroImaging, Inc.) with a 40× objective. Cells were excited at 340 and 380 nm and the change in fluorescence ratio values (F~340~/F~380~) as a function of time in individual cells within a field was recorded simultaneously. The percent of responding cells was obtained by dividing those with a Ca^2+^ signal to total cells recorded. The ratio of maximal F~340~/F~380~ induced by histamine to basal F~340~/F~380~ is defined as the Ca^2+^ peak. Ca^2+^ flux is defined as the slope of a line between the initiation of a persistent increase in F~340~/F~380~ and the maximal F~340~/F~380~.

Intracellular delivery of PIP~2~ by Shuttle PIP~2~
--------------------------------------------------

siRNA-treated cells were stimulated with 1 μM histamine in the absence of extracellular Ca^2+^ and ratio imaged. Histamine was washed out and cells were loaded with a mixture of 1 μM diC16-PIP~2~ and 1 μM of carrier 2 (Shuttle PIP~2~; Echelon Biosciences, Inc.) diluted in the Hank\'s buffer (PIP~2~) or buffer only (Mock; [@bib22]) for 10--15 min on the microscope stage. Cells were then reexposed to 1 μM histamine and imaged again.

Online supplemental material
----------------------------

Table S1 illustrates the effect of PIP5KI RNAi on PIP5KI protein expression. HeLa cells transfected with siRNA for each PIP5KI was lysed and subjected to Western blotting with isoform specific antibodies. Table S2 illustrates the effect of PIP5KI RNAi on histamine induced Ca^2+^ transients. HeLa cells transfected with siRNA were stimulated with histamine, and Ca^2+^ transients were recorded on single cells loaded with fura2. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.200408008/DC1>.
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